30
Participants
Start Date
April 24, 2025
Primary Completion Date
July 1, 2027
Study Completion Date
December 1, 2027
GR1803
D1 given at a dose of 10ug/kg, D4 given at a dose of 30ug/kg, D8 given at a dose of 180ug/kg, followed by weekly dosing up to cycle 9, and cycle 10 and onwards, every 2 weeks, with a dosing cycle of every 4 weeks
RECRUITING
Institute of Hematology & Blood Diseases Hospital, Tianjin
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
INDUSTRY